LA JOLLA, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE SCRIPPS RESEARCH INSTITUTE, founded in 1924, is a major nonprofit in the Medical Research sector that reported $641.1M in total revenue in fiscal year 2023. Revenue fell 21% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $112.7M, a strong 18% operating margin.
THE SCRIPPS RESEARCH INSTITUTE ("TSRI") PERFORMS HIGH IMPACT BASIC BIOMEDICAL RESEARCH, IMPROVES THE HUMAN CONDITION BY FOSTERING TRANSLATION OF ITS DISCOVERIES INTO USEFUL PRODUCTS AND ENGAGES IN THE HIGHEST QUALITY GRADUATE SCIENTIFIC EDUCATION AND POST GRADUATE SCIENTIFIC TRAINING. TSRI IS KNOWN FOR ITS ENTREPRENEURIAL ENVIRONMENT AND ITS EMPHASIS IN RESEARCH RELATING TO SYNTHETIC CHEMISTRY, THE RELATIONSHIP BETWEEN MOLECULAR STRUCTURE AND ACTIVITY AND CHEMICAL BIOLOGY.
GROUNDBREAKING SCIENTIFIC RESEARCH IS CONDUCTED AT TSRI CAMPUSES IN LA JOLLA, CALIFORNIA, SUPPORTED BY GRANTS, CONTRACTS AND FELLOWSHIPS FROM PUBLIC AND PRIVATE INSTITUTES AND INDIVIDUALS. TSRI'S...
GROUNDBREAKING SCIENTIFIC RESEARCH IS CONDUCTED AT TSRI CAMPUSES IN LA JOLLA, CALIFORNIA, SUPPORTED BY GRANTS, CONTRACTS AND FELLOWSHIPS FROM PUBLIC AND PRIVATE INSTITUTES AND INDIVIDUALS. TSRI'S UNIQUE STRUCTURE MERGES BASIC SCIENTIFIC STUDIES IN BIOLOGY, CHEMISTRY AND BIOINFORMATICS WITH TRANSLATIONAL SCIENCE TO PRODUCE THE NEXT GENERATION OF DRUGS AND ADVANCES IN DIGITAL AND PRECISION MEDICINE. SCIENTIFIC DISCOVERIES AT TSRI SEED JOINT DRUG DISCOVERY PROJECTS AT CALIBR-SKAGGS, A DIVISION OF TSRI, CREATING A PIPELINE OF DRUG CANDIDATES THAT WILL IMPACT PATIENTS FOR YEARS TO COME. THE SCRIPPS RESEARCH TRANSLATIONAL INSTITUTE, ANOTHER DIVISION OF TSRI, AIMS TO INDIVIDUALIZE HEALTHCARE BY LEVERAGING THE PROGRESS BEING MADE IN HUMAN GENOMICS AND COMBINING IT WITH THE POWER OF WIRELESS DIGITAL TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE.
TSRI IS COMMITTED TO EDUCATING, TRAINING AND INSPIRING THE SCIENTISTS OF TOMORROW. THE INSTITUTE'S SKAGGS GRADUATE SCHOOL OF CHEMICAL AND BIOLOGICAL SCIENCES, RANKED ONE OF THE TEN BEST GRADUATE...
TSRI IS COMMITTED TO EDUCATING, TRAINING AND INSPIRING THE SCIENTISTS OF TOMORROW. THE INSTITUTE'S SKAGGS GRADUATE SCHOOL OF CHEMICAL AND BIOLOGICAL SCIENCES, RANKED ONE OF THE TEN BEST GRADUATE PROGRAMS IN THE COUNTRY, EMPOWERS STUDENTS TO MAKE HIGH-IMPACT DISCOVERIES AT THE INTERFACE OF CHEMISTRY AND BIOLOGY. STUDENTS IN THE SKAGGS GRADUATE SCHOOL ARE IMMERSED IN INTENSIVE LABORATORY RESEARCH FROM DAY ONE AND PURSUE AMBITIOUS INVESTIGATIONS ACROSS SCIENTIFIC DISCIPLINES. GRADUATES OF THE SCHOOL BECOME EDUCATORS AT TOP UNIVERSITIES AND RESEARCH INSTITUTES, THOUGHT LEADERS WITHIN GOVERNMENT DEPARTMENTS AND INNOVATORS AT PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES. POSTDOCTORAL ASSOCIATES ARRIVE AT TSRI FROM ALL OVER THE GLOBE, SEEKING TO EXPAND THEIR KNOWLEDGE AND TRAINING BY WORKING ALONGSIDE OUR WORLD-RENOWNED SCIENTISTS. THE SCRIPPS FELLOWS PROGRAM IDENTIFIES INDIVIDUALS WITH AN OUTSTANDING RECORD OF GRADUATE RESEARCH AND MOVES THEM INTO THEIR OWN LABORATORIES, ALLOWING THEM TO LEAPFROG THEIR POSTDOCTORAL YEARS OF STUDY AND BEGIN PUSHING THE FRONTIERS OF SCIENTIFIC DISCOVERY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $641,106,163 | $815,837,195 | -0.2% |
| Expenses | $528,437,793 | $532,639,503 | 0.0% |
| Net Income | $112,668,370 | $283,197,692 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PETER G SCHULTZ | PRESIDENT/CEO | 40.00 |
Officer
Director
|
$1,719,942 | $75,701 | $1,795,643 |
| ARDEM PATAPOUTIAN | FACULTY DIRECTOR/PROFESSOR | 40.00 |
Director
|
$129,755 | $1,354 | $131,109 |
| JOHN D DIEKMAN | DIRECTOR/BOARD CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| BARBARA KOSACZ | DIRECTOR (START 4/24) | 1.00 |
Director
|
$0 | $0 | $0 |
| BENEDICT GROSS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CLAUDIA S LUTTRELL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GENE LAY | DIRECTOR (START 11/23) | 1.00 |
Director
|
$0 | $0 | $0 |
| GERALD CHAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HERBERT WERTHEIM | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEN RUBIO | DIRECTOR (END 12/23) | 1.00 |
Director
|
$0 | $0 | $0 |
| LILLIAN LOU | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARK EDWARDS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARK PEARSON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PETER C FARRELL PHD D SC | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RON BURKLE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SHERRY LANSING | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TOM DANIEL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CAROLINE MOON | COO (END 9/24)/CFO | 40.00 |
Officer
|
$794,373 | $68,471 | $862,844 |
| MARSHALL OLIN | GENERAL COUNSEL | 40.00 |
Officer
|
$584,449 | $76,054 | $660,503 |
| JARED M MACHADO | TREASURER/CHIEF ACCOUNTING OFFICER | 40.00 |
Officer
|
$360,003 | $50,895 | $410,898 |
| ALANNA RUTAN | SECRETARY/CHIEF COMPLIANCE OFFICER | 40.00 |
Officer
|
$261,520 | $41,709 | $303,229 |
| MARY WANG | ASST. SEC./DIRECTOR SP (END 2/24) | 40.00 |
Officer
|
$225,864 | $43,395 | $269,259 |
| KELLY SAN GEORGE | CFO VP ADM. CALIBR | 40.00 |
Key Emp
|
$461,839 | $69,228 | $531,067 |
| JAMES R WILLIAMSON | VP, RSCH & ACAD AFFAIRS (END 1/23) | 40.00 |
Key Emp
|
$385,731 | $46,402 | $432,133 |
| ERIC TOPOL | PROFESSOR/EXEC VP | 40.00 |
Highest
|
$1,055,042 | $29,206 | $1,084,248 |
| ISY H GOLDWASSER | ENTREPRENEUR IN RESIDENCE | 40.00 |
Highest
|
$739,338 | $41,317 | $780,655 |
| TRAVIS SCOTT YOUNG | SR. DIRECTOR, CALIBR | 40.00 |
Highest
|
$566,858 | $57,607 | $624,465 |
| CHANNING R BEALS | CHIEF MEDICAL OFFICER | 40.00 |
Highest
|
$529,571 | $84,007 | $613,578 |
| VADIM KLYUSHNICHENKO | VP, PHARMACEUTICAL DEV & QUAL | 40.00 |
Highest
|
$562,460 | $32,363 | $594,823 |
| MATTHEW S TREMBLAY | FORMER CHIEF OPERATING OFFICER | 0.00 |
|
$166,206 | $14,358 | $180,564 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $641,106,163 | $528,437,793 | $1,299,917,796 | $112,668,370 |
| 2023 | $815,837,195 | $532,639,503 | $1,088,712,998 | $283,197,692 |
| 2022 | $634,980,417 | $884,961,642 | $828,320,768 | $-249,981,225 |
| 2021 | $537,087,759 | $473,843,953 | $1,160,188,604 | $63,243,806 |
| 2020 | $414,846,612 | $444,003,884 | $973,580,297 | $-29,157,272 |
| 2019 | $412,183,981 | $432,597,967 | $962,297,107 | $-20,413,986 |
| 2018 | $380,130,505 | $373,107,791 | $791,941,824 | $7,022,714 |
Compare THE SCRIPPS RESEARCH INSTITUTE with other nonprofits in California and across the country.